Frontlight ResearchEarly access
Peripheral artery disease trials in Greece
4 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in GreeceReducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Where
- Athens
- Age
- 18 years and over
- People
- 7,050 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07318610 · EU 2025-522954-37-00 - Phase 3Not yet taking people in GreeceEfficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- Where
- Athens, Chaïdári, Heraklion, Ioannina, Thessaloniki
- Age
- 18 years and over
- People
- 1,205 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07223593 · EU 2025-523283-21-00 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Alexandroupoli, Arta, Athens, Crete, Haidari, Ioannina, Larissa, Marousi, Ptolemaida, Rio, Thessaloniki
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - No phaseTaking peoplePressure (Fractional Flow Reserve) and Flow (Vascular Flow Reserve) Measurements During Peripheral Arterial Interventions
- Where
- Pátrai
- People
- 100
- Run by
- Dr. Konstantinos Katsanos
See details and how to joinNCT07052435